Latest Nyctalopia Stories

2010-10-18 13:56:14

Oct. 18 AAO-MEACO 2010 Joint Meeting scientific program Today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases. The AAO-MEACO meeting"“the world's largest, most comprehensive ophthalmic education conference"“is in session October 16 through 19 at McCormick Place, Chicago. 9-cis...

2010-08-05 13:56:27

Neurobiologists funded by the Office of Naval Research (ONR) have discovered a potential cure for degenerative vision diseases leading to terminal blindness. The solution, however, may be rooted in an unconventional therapeutic approach. Scientists at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, are manipulating the proteins that cause blindness in mice. The scientists have successfully restored vision in the light-sensing cells of the retina. Dr. Thomas...

2010-07-15 04:29:00

TOKYO, July 15 /PRNewswire/ -- R-Tech Ueno, Ltd. announced on July 15 the completion of the Phase II clinical study on the ophthalmic solution UF-021 (product name Ocuseva (TM)) under development as a therapeutic drug for retinitis pigmentosa (Note 1). Below is a summary of the detailed results of the study. - Description - The Phase II clinical study ("this study" hereafter) on the ophthalmic solution UF-021 (product name Ocuseva (TM)) for retinitis pigmentosa, a refractory disease for...

2010-06-03 04:20:00

TOKYO, June 3 /PRNewswire/ -- We are pleased to announce that the Phase II clinical study of UF-021, product name Ocuseva (TM), which we are developing as a therapeutic drug for retinitis pigmentosa (note 1), has been completed. Retinitis pigmentosa is an intractable disease where therapeutic drugs or therapeutic methods have not been established yet. When the disease of retinitis pigmentosa progresses, the visual field narrows irreversibly and furthermore, in the late stage, they may...

2004-11-25 15:00:08

Moran Eye Center researchers have found gene mutations that result in retinitis pigmentosa (RP), one of the leading causes of blindness. The discovery has raised fears that medications commonly used to treat both heart disease and glaucoma may trigger the eye disease in even those without the mutation because of similarities in what the mutations and the drugs do to the eyes. The research, published in the online version of Human Molecular Genetics Wednesday, says each gene mutation...

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.